Patient Immunotherapy Summit: Pancreatic Cancer Brief

Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading cause of cancer deaths in the U.S.  

Elizabeth M. Jaffee, MD, the Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and CRI Scientific Advisory Council associate director, focuses her research on pancreatic cancer. Dr. Jaffee gives a detailed overview of pancreatic cancer and its treatment landscape.


Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son